LOPEZ GEORGE A 4
4 · ICU MEDICAL INC/DE · Filed Apr 30, 2021
Insider Transaction Report
Form 4
LOPEZ GEORGE A
DirectorChairmanOther
Transactions
- Sale
Common Stock
2021-04-23$214.64/sh−11$2,361→ 886,843 total(indirect: By Partnership) - Sale
Common Stock
2021-04-22$213.58/sh−5,089$1,086,914→ 906,754 total(indirect: By Partnership) - Sale
Common Stock
2021-04-22$215.29/sh−1,970$424,121→ 899,858 total(indirect: By Partnership) - Sale
Common Stock
2021-04-22$214.64/sh−4,926$1,057,297→ 901,828 total(indirect: By Partnership) - Sale
Common Stock
2021-04-23$213.04/sh−6,804$1,449,550→ 890,383 total(indirect: By Partnership) - Sale
Common Stock
2021-04-23$211.82/sh−2,671$565,771→ 897,187 total(indirect: By Partnership) - Sale
Common Stock
2021-04-23$213.79/sh−3,529$754,480→ 886,854 total(indirect: By Partnership)
Holdings
- 240,314
Common Stock
Footnotes (8)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.09 to $214.08, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.14 to $215.13, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.16 to $215.78, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.48 to $212.45, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.55 to $213.52, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.55 to $213.97, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4.
- [F8]All shares sold were sold at the exact price disclosed.